EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pharmacokinetic Characterization of Iopamidol and Iohexol for Optimizing Measured Glomerular Filtration Rate Assessment in Clinical Practice and Drug Development

Levi Hooper, Michael Heung, Lu Wang, Aleksas Matvekas, Radin Alikhani, Michael T Kenes, Kathleen A Stringer iD, Bruce A Mueller iD, Manjunath P Pai iD

The Journal of Clinical Pharmacology · 2025-11 · 65 (11) · 1350-1361

DOI: 10.1002/jcph.70046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Pharmacology, online erschienen am 21.05.2025. Verfasst von Levi Hooper und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Iohexol, Glomerular Filtration Rate, Contrast Media, Iopamidol. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: AHRQ HHS, NIGMS NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate kidney function assessment supports healthcare and clinical decision‐making in practice and drug development. Measured glomerular filtration rate (mGFR) via iohexol clearance is the gold standard, but cost, supply issues, and logistical challenges limit its clinical use. Iopamidol, another iodinated contrast agent widely used in CT imaging, has not been studied in humans for mGFR assessment. This study aims to evaluate the pharmacokinetic interchangeability of iohexol and iopamidol for mGFR assessment and to develop a limited sampling strategy to facilitate clinical implementation. In a parallel‐group, single‐dose pharmacokinetic study, 24 healthy adult volunteers with varying kidney function, as defined by the 2021 CKD‐EPI eGFRcr equation (range: 35‐140 mL/min; median: 72 mL/min), received iohexol and iopamidol. Plasma concentrations were measured using liquid chromatography‐mass spectrometry, and population pharmacokinetic modeling estimated drug clearance. Clearance estimates for both agents showed strong agreement (R 2 = 0.82, P < .005), with Bland–Altman analysis indicating minimal bias (mean difference: 15.69 mL/min; LoA: −3.76 to 35.15). A limited sampling strategy using one (1‐h, R 2 = 0.91) or two (1 and 5 h, R 2 = 0.92) time points yielded accurate clearance estimates. These findings suggest that iopamidol may be a viable alternative to iohexol for mGFR determination. Broader access to accurate kidney function testing can enhance drug dosing, reduce misclassification, and improve care for patients with chronic kidney disease. Further research should validate these findings in larger, more diverse populations, including those with advanced kidney impairment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IohexolGlomerular Filtration RateContrast MediaIopamidolHumansMaleAdultFemaleMiddle AgedYoung AdultDrug DevelopmentModels, Biological

Stichwörter der Autor:innen

kidney functionlimited sampling strategymeasured GFRpopulation pharmacokinetics

Substanzen

IohexolContrast MediaIopamidol

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Internal Medicine, Division of Nephrology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Division of Pulmonary and Critical Care Medicine, School of Medicine, University of Michigan, Ann Arbor, Michigan, USA.

ORCID-Profile: Kathleen A Stringer, Bruce A Mueller, Manjunath P Pai

Förderung

  • AHRQ HHS
  • NIGMS NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Hooper, L., Heung, M., Wang, L., Matvekas, A., Alikhani, R., Kenes, M. T., Stringer, K. A., Mueller, B. A., & Pai, M. P. (2025). Pharmacokinetic Characterization of Iopamidol and Iohexol for Optimizing Measured Glomerular Filtration Rate Assessment in Clinical Practice and Drug Development. The Journal of Clinical Pharmacology, 65(11), 1350-1361. https://doi.org/10.1002/jcph.70046

Vancouver

Hooper L, Heung M, Wang L, Matvekas A, Alikhani R, Kenes MT, et al. Pharmacokinetic Characterization of Iopamidol and Iohexol for Optimizing Measured Glomerular Filtration Rate Assessment in Clinical Practice and Drug Development. The Journal of Clinical Pharmacology. 2025;65(11):1350-1361. doi:10.1002/jcph.70046

BibTeX
@article{Hooper2025,
  author = {Hooper, Levi and Heung, Michael and Wang, Lu and Matvekas, Aleksas and Alikhani, Radin and Kenes, Michael T and Stringer, Kathleen A and Mueller, Bruce A and Pai, Manjunath P},
  title = {Pharmacokinetic Characterization of Iopamidol and Iohexol for Optimizing Measured Glomerular Filtration Rate Assessment in Clinical Practice and Drug Development},
  journal = {The Journal of Clinical Pharmacology},
  year = {2025},
  volume = {65},
  number = {11},
  pages = {1350--1361},
  doi = {10.1002/jcph.70046}
}
Kostenlos starten →